Agilon Health (AGL) Common Equity (2020 - 2026)

Agilon Health has reported Common Equity for 7 years, with the latest figure at $181.4 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 63.73% year-over-year to $181.4 million; the trailing twelve-month figure through Mar 2026 stood at $181.4 million (down 63.73% YoY), and the FY2025 full-year result was $126.7 million, down 73.09% from the prior year.
• Common Equity for Q1 2026 stood at $181.4 million, up from $126.7 million in the prior quarter.
• The five-year high for Common Equity was $1.1 billion in Q1 2022, with the low at $126.7 million in Q4 2025.
• Historically, Common Equity has averaged $692.3 million across 5 years, with a median of $675.9 million in 2024.
• Annual changes were most pronounced in 2022 — Common Equity jumped 472.67% — and 2025, when it slumped 73.09%.
• Agilon Health's Common Equity stood at $1.0 billion in 2022, then tumbled by 36.48% to $661.0 million in 2023, then retreated by 28.75% to $471.0 million in 2024, then tumbled by 73.09% to $126.7 million in 2025, then soared by 43.16% to $181.4 million in 2026.
• The last three Common Equity figures came in at $181.4 million (Q1 2026), $126.7 million (Q4 2025), and $306.1 million (Q3 2025), per Business Quant data.